ProMab Biotechnologies has 2 decades of experience generating highly specific and potent monoclonal antibodies. We have generated thousands of hybridoma cell lines for our catalog and custom projects for clients from academic institutions and pharmaceutical companies.
ProMab can help you advance your antibody research & development with our well established platform. Over the years, we have invested in multitudes of antibody technology including antibody humanization, recombinant antibody technology, and bispecific antibody development. Paired alongside our monoclonal antibody development platform in producing hundreds and thousands of hybridomas, this allows us to sequence and immortalize the antibodies that work best. It also allows us to engineer cell lines to express antibodies of interest and cell lines of interest, such as distinct antibody producing stable cell lines. Inquire today about your custom project.